Our findings indicated that high LC3 expression remarkably associated with mild clinicopathological features and improved OS and DFS in cHCC-CC patients and that LC3 may serve as an important prognostic factor to predict OS and DFS in cHCC-CC patients after surgical resection. The gene discussed is MAP1LC3A; the disease is cholangiocarcinoma.